Induction of monocyte chemoattractant protein-1 in the small veins of the ischemic and reperfused canine myocardium

Circulation

Volumn 95, Issue 3, 1997, Pages 693-700

  Kumar, Ajith G ^a   Ballantyne, Christie M ^a   Michael, Lloyd H ^a   Kukielka, Gilbert L ^a   Youker, Keith A ^a   Lindsey, Merry L ^a   Hawkins, Hal K ^e   Birdsall, Holly H ^d   MacKay, Charles R ^f   LaRosa, Gregory J ^f   Rossen, Roger D ^c   Smith, C Wayne ^b   Entman, Mark L ^a,d  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

^c MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e University of Texas Medical Branch School of Medicine   (United States)

^f MILLENNIUM PHARMACEUTICALS INC   (United States)

Author keywords

cytokines; myocardial infarction; proteins, monocyte chemoattractant; reperfusion

Indexed keywords

COMPLEMENTARY DNA; CYTOKINE; INTERLEUKIN 4; INTERLEUKIN 6; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DOG; ENDOTHELIUM CELL; HEART MUSCLE; HEART MUSCLE REPERFUSION; ISCHEMIC HEART DISEASE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

EID: 16844387569     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.95.3.693     Document Type: Article

References (11)

1. Sommers HM, Jennings RB. Experimental acute myocardial infarction: histologic and histochemical studies of early myocardial infarcts induced by temporary or permanent occlusion of a coronary artery. Lab Invest. 1964;13:1491-1503.
2. Kim CB, Braunwald E. Potential benefits of late reperfusion of infarcted myocardium. Circulation. 1993;88:2426-2436.
3. Richard V, Murry CE, Reimer KA. Healing of myocardial infarcts in dogs: effects of late reperfusion. Circulation. 1995;92:1891-1901.
4. Entman ML, Smith CW. Post-reperfusion inflammation: a model of reaction to injury in cardiovascular disease. Cardiovasc Res. 1994;28:1301-1311.
5. Hammerman H, Kloner RA, Hale S, Schocn FJ, Braunwald E. Dose-dependent effects of short-term methylprednisolone on myocardial infarct extent, scar formation, and ventricular function. Circulation. 1983;68:446-452.
6. Roberts R, DeMello V, Sobel BE. Deleterious effects of methylprednisolone in patients with myocardial infarction. Circulation. 1976;53(suppl I):I-204-I-206.
7. Mallory GK, White PD, Salcedo-Salgar J. The speed of healing of myocardial infarction: a study of the pathologic anatomy in seventy-two cases. Am Heart J. 1939;18:647-671.
8. Karsner HT, Dwyer JE Jr. Studies in infarction, IV: experimental bland infarction of the myocardium, myocardial regeneration and cicatrization. J Med Res. 1916;34:21-41.
9. Boyle MP, Weisman HF. Limitation of infarct expansion and ventricular remodeling by late reperfusion. Circulation. 1993;88:2872-2883.
10. Monta M, Kawashima S, Ueno M, Kubota A, Iwasaki T. Effects of late reperfusion on infarct expansion and infarct healing in conscious rats. Am J Pathol. 1993;143:419-430.
11. Dreyer WJ, Smith CW, Michael LH, Rossen RD, Hughes BJ, Entman ML, Anderson DC. Canine neutrophil activation by cardiac lymph obtained during reperfusion of ischemic myocardium. Circ Res. 1989;65:1751-1762.